Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity
暂无分享,去创建一个
[1] A. Ma,et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. , 2000, Science.
[2] S. Akira,et al. Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.
[3] James R. Johnson,et al. Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression , 2004, Science.
[4] B. Aggarwal,et al. Nuclear factor-kappaB: the enemy within. , 2004, Cancer cell.
[5] Yukio Nakamura,et al. Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts , 1999, Oncogene.
[6] R. Gaynor,et al. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. , 2001, The Journal of clinical investigation.
[7] J. Darnell. Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.
[8] H. Pahl. Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.
[9] A. Hoffmann,et al. The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .
[10] M J May,et al. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.
[11] B. Beutler,et al. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.
[12] H. Haikala,et al. Mechanisms of action of calcium-sensitizing drugs. , 1995, Journal of cardiovascular pharmacology.
[13] Ruslan Medzhitov,et al. Toll-Like Receptor Signaling Pathways , 2003, Science.
[14] Michael Karin,et al. The IKK NF-κB system: a treasure trove for drug development , 2004, Nature Reviews Drug Discovery.
[15] Somasekar Seshagiri,et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.